Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells

C Bolden, B Cusack and E Richelson

Department of Psychiatry, Mayo Clinic Jacksonville, Florida.

We determined the affinity and selectivity of binding for 24 compounds: nine antimuscarinics (including some antiparkinson drugs) and 15 neuroleptics (including the atypical compounds clozapine, fluperlapine, melperone, rilapine, risperidone, tenilapine, tiosperone and zotepine) at the five human muscarinic receptor subtypes expressed in Chinese hamster ovary cells. Equilibrium dissociation constants (Kd) were obtained from competitive radioligand binding studies with [3H]quinuclidinyl benzilate and membranal preparations of these cells. As expected, QNB had the highest affinity of the compounds studied at the five receptor subtypes and was not selective (Kd ranged from 0.027- 0.088 nM). Benztropine had the next highest affinity of the antimuscarinic compounds and thioridazine had the highest affinity of the neuroleptics. Among the antiparkinson drugs, biperiden was the only one selective for the m1 subtype; and among the neuroleptics, the atypical drug clozapine was also selective for the m1 subtype. This selectivity may explain clozapine's unusual efficacy in refractory schizophrenic patients and its low incidence of extrapyramidal side effects. However, because most other atypical neuroleptics studied lacked high affinity and selectivity at muscarinic receptor subtypes, it is likely that other mechanisms are involved as well.

Volume 260, Issue 2, pp. 576-580, 02/01/1992
Copyright © 1992 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				A. Thomas, D. Nallur, N. Jones, and P. Deslandes Diphenhydramine abuse and detoxification: a brief review and case report J Psychopharmacol, January 1, 2009; 23(1): 101 - 105. [Abstract] [PDF]

				S. R. McGurk, C. Carter, R. Goldman, M. F. Green, S. R. Marder, H. Xie, N. R. Schooler, and J. M. Kane The Effects of Clozapine and Risperidone on Spatial Working Memory in Schizophrenia Am J Psychiatry, May 1, 2005; 162(5): 1013 - 1016. [Abstract] [Full Text] [PDF]

				D. E. Johnson, H. Yamazaki, K. M. Ward, A. W. Schmidt, W. S. Lebel, J. L. Treadway, E. M. Gibbs, W. S. Zawalich, and H. Rollema Inhibitory Effects of Antipsychotics on Carbachol-Enhanced Insulin Secretion From Perifused Rat Islets: Role of Muscarinic Antagonism in Antipsychotic-Induced Diabetes and Hyperglycemia Diabetes, May 1, 2005; 54(5): 1552 - 1558. [Abstract] [Full Text] [PDF]

				C. Sur, P. J. Mallorga, M. Wittmann, M. A. Jacobson, D. Pascarella, J. B. Williams, P. E. Brandish, D. J. Pettibone, E. M. Scolnick, and P. J. Conn N-desmethylclozapine, an allosteric agonist at muscarinic 1 receptor, potentiates N-methyl-D-aspartate receptor activity PNAS, November 11, 2003; 100(23): 13674 - 13679. [Abstract] [Full Text] [PDF]

				T. J. Raedler, M. B. Knable, D. W. Jones, R. A. Urbina, J. G. Gorey, K. S. Lee, M. F. Egan, R. Coppola, and D. R. Weinberger In Vivo Determination of Muscarinic Acetylcholine Receptor Availability in Schizophrenia Am J Psychiatry, January 1, 2003; 160(1): 118 - 127. [Abstract] [Full Text] [PDF]

				S. K. Hemrick-Luecke, F. P. Bymaster, D. C. Evans, J. Wess, and C. C. Felder Muscarinic Agonist-Mediated Increases in Serum Corticosterone Levels Are Abolished in M2 Muscarinic Acetylcholine Receptor Knockout Mice J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 99 - 103. [Abstract] [Full Text] [PDF]

				C. RICHARDSON, D. L. KELLY, and R. R. CONLEY Biperiden for Excessive Sweating From Clozapine Am J Psychiatry, August 1, 2001; 158(8): 1329 - 1330. [Full Text]

				S. J. Graham, R. W. Langley, C. M. Bradshaw, and E. Szabadi Effects of haloperidol and clozapine on prepulse inhibition of the acoustic startle response and the N1/P2 auditory evoked potential in man J Psychopharmacol, July 1, 2001; 15(4): 243 - 250. [Abstract] [PDF]

				J. M. Crook, E. Tomaskovic-Crook, D. L. Copolov, and B. Dean Low Muscarinic Receptor Binding in Prefrontal Cortex From Subjects With Schizophrenia: A Study of Brodmann's Areas 8, 9, 10, and 46 and the Effects of Neuroleptic Drug Treatment Am J Psychiatry, June 1, 2001; 158(6): 918 - 925. [Abstract] [Full Text] [PDF]

				C. K. Jones and H. E. Shannon Muscarinic Cholinergic Modulation of Prepulse Inhibition of the Acoustic Startle Reflex J. Pharmacol. Exp. Ther., September 1, 2000; 294(3): 1017 - 1023. [Abstract] [Full Text]

				H. A. Baghdoyan, R. Lydic, and M. A. Fleegal M2 Muscarinic Autoreceptors Modulate Acetylcholine Release in the Medial Pontine Reticular Formation J. Pharmacol. Exp. Ther., September 1, 1998; 286(3): 1446 - 1452. [Abstract] [Full Text]

				I. Kovacs, H. I. Yamamura, S. L. Waite, E. V. Varga, and W. R. Roeske Pharmacological Comparison of the Cloned Human and Rat M2 Muscarinic Receptor Genes Expressed in the Murine Fibroblast (B82) Cell Line J. Pharmacol. Exp. Ther., February 1, 1998; 284(2): 500 - 507. [Abstract] [Full Text]

				S. L. Purkerson and L. T. Potter Use of Antimuscarinic Toxins To Facilitate Studies of Striatal m4 Muscarinic Receptors J. Pharmacol. Exp. Ther., February 1, 1998; 284(2): 707 - 713. [Abstract] [Full Text]

				A. U. Höglund and H. A. Baghdoyan M2, M3 and M4, but not M1, Muscarinic Receptor Subtypes are Present in Rat Spinal Cord J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 470 - 477. [Abstract] [Full Text]

				J. W. Olney and N. B. Farber Glutamate Receptor Dysfunction and Schizophrenia Arch Gen Psychiatry, December 1, 1995; 52(12): 998 - 1007. [Abstract] [PDF]